{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:42:39Z","timestamp":1793036559090,"version":"4.5.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ejmech.2025.118067","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T06:20:39Z","timestamp":1755498039000},"page":"118067","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Discovery of a selenium-containing compound as a promising ferroptosis inducer attenuates prostate cancer progression"],"prefix":"10.1016","volume":"299","author":[{"given":"Lei","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianhao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoqun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5852-0226","authenticated-orcid":false,"given":"Zi","family":"Che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.118067_bib1","article-title":"Translational bioinformatics for diagnostic and prognostic prediction of prostate cancer in the next-generation sequencing era","volume":"2013","author":"Chen","year":"2013","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.ejmech.2025.118067_bib2","first-page":"27","article-title":"Prostate cancer review: Genetics, diagnosis, treatment options, and alternative approaches","author":"Sekhoacha","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.118067_bib3","doi-asserted-by":"crossref","first-page":"e349","DOI":"10.1016\/j.canep.2012.07.012","article-title":"Epidemiology of castration resistant prostate cancer: a longitudinal analysis using a UK primary care database","volume":"36","author":"Hirst","year":"2012","journal-title":"Cancer Epidemiol."},{"key":"10.1016\/j.ejmech.2025.118067_bib4","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1200\/JCO.2005.01.529","article-title":"Natural history of rising serum prostate-specific antigen in men with castrate nonmetastatic prostate cancer","volume":"23","author":"Smith","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejmech.2025.118067_bib5","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nrc801","article-title":"A history of prostate cancer treatment","volume":"2","author":"Denmeade","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejmech.2025.118067_bib6","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/j.1742-1241.2011.02799.x","article-title":"Characterising the castration-resistant prostate cancer population: a systematic review","volume":"65","author":"Kirby","year":"2011","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.ejmech.2025.118067_bib7","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12943-022-01530-y","article-title":"Ferroptosis in cancer therapy: a novel approach to reversing drug resistance","volume":"21","author":"Zhang","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ejmech.2025.118067_bib8","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/cac2.12250","article-title":"Ferroptosis in cancer and cancer immunotherapy","volume":"42","author":"Zhao","year":"2022","journal-title":"Cancer Commun."},{"key":"10.1016\/j.ejmech.2025.118067_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/cells12141820","article-title":"Ferroptosis in cancer progression","volume":"12","author":"Zhang","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.ejmech.2025.118067_bib10","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41388-022-02537-x","article-title":"CST1 inhibits ferroptosis and promotes gastric cancer metastasis by regulating GPX4 protein stability via OTUB1","volume":"42","author":"Li","year":"2023","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2025.118067_bib11","doi-asserted-by":"crossref","first-page":"4352","DOI":"10.1016\/j.molcel.2023.10.042","article-title":"SMURF2 predisposes cancer cell toward ferroptosis in GPX4-independent manners by promoting GSTP1 degradation","volume":"83","author":"Zhang","year":"2023","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejmech.2025.118067_bib12","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1038\/s41418-022-01008-w","article-title":"Wnt\/beta-catenin signaling confers ferroptosis resistance by targeting GPX4 in gastric cancer","volume":"29","author":"Wang","year":"2022","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejmech.2025.118067_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101877","article-title":"A matter of concern - trace element dyshomeostasis and genomic stability in neurons","volume":"41","author":"Wandt","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejmech.2025.118067_bib14","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1074\/jbc.R800045200","article-title":"Selenoproteins","volume":"284","author":"Lu","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.118067_bib15","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.cell.2017.11.048","article-title":"Selenium utilization by GPX4 is required to prevent hydroperoxide-induced ferroptosis","volume":"172","author":"Ingold","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2025.118067_bib16","doi-asserted-by":"crossref","first-page":"11634","DOI":"10.1021\/acs.jafc.5c02034","article-title":"Selenium nanoparticles vs selenite fertilizers: implications for toxicological profiles, antioxidant defense, and ferroptosis pathways","volume":"73","author":"Fang","year":"2025","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ejmech.2025.118067_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102962","article-title":"Organic Selenium induces ferroptosis in pancreatic cancer cells","volume":"68","author":"No\u00e8","year":"2023","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejmech.2025.118067_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16162776","article-title":"Liver X receptors enhance epithelial to mesenchymal transition in metastatic prostate cancer cells","volume":"16","author":"Bouchareb","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.ejmech.2025.118067_bib19","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1532-5415.2008.02091.x","article-title":"Cause of death in older men after the diagnosis of prostate cancer","volume":"57","author":"Ketchandji","year":"2009","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.ejmech.2025.118067_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13112750","article-title":"Diversity of epithelial-mesenchymal phenotypes in circulating tumour cells from prostate cancer patient-derived xenograft models","volume":"13","author":"Hassan","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.ejmech.2025.118067_bib21","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/pros.23940","article-title":"The stem cell inhibitor salinomycin decreases colony formation potential and tumor-initiating population in docetaxel-sensitive and docetaxel-resistant prostate cancer cells","volume":"80","author":"Gruber","year":"2020","journal-title":"Prostate"},{"key":"10.1016\/j.ejmech.2025.118067_bib22","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","article-title":"Regulation of ferroptotic cancer cell death by GPX4","volume":"156","author":"Yang","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2025.118067_bib23","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41417-020-0182-y","article-title":"Interplay between MTOR and GPX4 signaling modulates autophagy-dependent ferroptotic cancer cell death","volume":"28","author":"Liu","year":"2021","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.ejmech.2025.118067_bib24","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nchembio.2079","article-title":"Global survey of cell death mechanisms reveals metabolic regulation of ferroptosis","volume":"12","author":"Shimada","year":"2016","journal-title":"Nat. Chem. Biol."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425008323?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425008323?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T17:38:40Z","timestamp":1757180320000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425008323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":24,"alternative-id":["S0223523425008323"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118067","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of a selenium-containing compound as a promising ferroptosis inducer attenuates prostate cancer progression","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118067","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118067"}}